Ocular release of timolol from molecularly imprinted soft contact lenses

Biomaterials

Volumn 26, Issue 11, 2005, Pages 1293-1298

  Hiratani, Haruyuki ^a   Fujiwara, Akihito ^a   Tamiya, Yuka ^a   Mizutani, Yuri ^a   Alvarez Lorenzo, Carmen ^b  

^a MENICON CO LTD   (Japan)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Contact lens; Controlled drug release; Hydrogel; Molecular imprinting; Timolol

Indexed keywords

DISEASE CONTROL; DRUG DOSAGE; PATIENT TREATMENT;

DRUG DEVICES; EYEDROPS; MOLECULAR IMPRINTING TECHNOLOGY;

CONTACT LENSES;

ACRYLAMIDE DERIVATIVE; BRUNNE; ETHYLENE GLYCOL DIMETHACRYLATE; EYE DROPS; METHACRYLIC ACID; MONOMER; N,N DIETHYLACRYLAMIDE; TIMOLOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORNEA; CROSS LINKING; DRUG BIOAVAILABILITY; DRUG RELEASE; LACRIMAL FLUID; MALE; MOLECULAR IMPRINTING; NONHUMAN; PRIORITY JOURNAL; RABBIT; SOFT CONTACT LENS; THICKNESS;

ABSORPTION; ANIMALS; BIOCOMPATIBLE MATERIALS; CONTACT LENSES, HYDROPHILIC; DELAYED-ACTION PREPARATIONS; DIFFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MATERIALS TESTING; METABOLIC CLEARANCE RATE; OPHTHALMIC SOLUTIONS; RABBITS; SURFACE PROPERTIES; TEARS; TIMOLOL;

ORYCTOLAGUS CUNICULUS;

EID: 4744363261     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2004.04.030     Document Type: Article

References (24)

1. Plazonnet B. Ophthalmic drug delivery. Rathbone M.J., Hadgraft J., Roberts M.S. Modified-release drug delivery technology. 2003;289-313 Marcel Dekker Inc., New York
2. Felt O., Einmahl S., Gurny R., Furrer P., Bayens V. Polymeric systems for ophthalmic drug delivery. Dimitriu S. Polymeric biomaterials. 2nd ed:2002;377-421 Marcel Dekker, Inc., New York
3. Ding S. Recent developments in ophthalmic drug delivery. Pharm Sci Technol. 1:1998;328-335
4. Herrero-Vanrell R., Fernández-Carballido A., Frutos G., Cadórniga R. Enhancement of the mydriatic response to tropicamide by bioadhesive polymers. J Ocul Pharmacol Ther. 16:2000;419-428
5. Bochot A., Fattal E., Gulik A., Couarraze G., Couvreur P. Liposomes dispersed within a thermosensitive gel. a new dosage form for ocular delivery of oligonucleotides Pharm Res. 15:1998;1364-1369
6. Srividya B., Cardoza R.M., Amin P.D. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Rel. 73:2001;205-211
7. Weyenberg W., Vermeire A., Remon J.P., Ludwig A. Characterization and in vivo evaluation of ocular bioadhesive minitablets compressed at different forces. J Control Rel. 89:2003;329-340
8. Hornof M., Weyenberg W., Ludwig A., Schnurch A.B. Mucoadhesive ocular insert based on thiolated poly(acrylic acid). development and in vivo evaluation in humans J Control Rel. 89:2003;419-428
9. Wajs G., Meslard J.C. Release of therapeutic agents from contact lenses. Crit Rev Ther Drug Carrier Syst. 2:1986;275-289
10. McMahon T.T., Zadnik K. Twenty-five years of contact lenses. The impact on cornea and ophthalmic practice. Cornea. 19:2000;730-740
11. Alvarez-Lorenzo C., Hiratani H., Gomez-Amoza J.L., Martinez-Pacheco R., Souto C., Concheiro A. Soft contact lenses capable of sustained delivery of timolol. J Pharm Sci. 91:2002;2182-2192
12. Hiratani H., Alvarez-Lorenzo C. Timolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acid. J Control Rel. 83:2002;223-230
13. Hiratani H., Alvarez-Lorenzo C. The nature of backbone monomers determines the performance of imprinted soft contact lenses as timolol drug delivery systems. Biomaterials. 25:2004;1105-1113
14. Wulff G., Gross T., Schonfeld R. Enzyme models based on molecularly imprinted polymers with strong esterase activity. Angew Chem Int Ed Engl. 36:1997;1962-1964
15. Mosbach K, Haupt K, Liu XC, Cormack PAG, Ramstrom O. Molecular imprinting. In: Barstch RA, Maeda M, editors. Molecular and ionic recognition with imprinted polymers, ACS Symposium Series, vol. 703. Washington, DC: ACS; 1998. p. 29-48.
16. Ito K., Chuang J., Alvarez-Lorenzo C., Watanabe T., Ando N., Grosberg A.Yu. Multiple point adsorption in a heteropolymer gel and the Tanaka approach to imprinting. experiment and theory Progr Polym Sci. 28:2003;1489-1515
17. Hiratani H., Alvarez-Lorenzo C., Chuang J., Guney O., Grosberg A.Yu., Tanaka T. Effect of reversible cross-linker, N,N-bis(acryloyl)cystamine, on calcium ion adsorption by imprinted gels. Langmuir. 17:2001;4431-4436
18. Byrne M.E., Park K., Peppas N.A. Molecular imprinting within hydrogels. Adv Drug Deliv Rev. 54:2002;149-161
19. Alvarez-Lorenzo C, Concheiro A. Molecularly imprinted polymers for drug delivery. J Chromatogr B 2004, in press.
20. Rowland M., Tozer T.N. Clinical pharmacokinetics. concepts and applications:1989;Lea & Febiger, Philadelphia. p. 479-85
21. Sasaki H., Yamamura K., Mukai T., Nishida K., Nakamura J., Nakashima M., Ogasawara M., Ichikawa M. In vivo ocular pharmacokinetic model for designing dosage schedules and formulations of ophthalmic drugs in human. Acta Med Nagasaki. 42:1997;45-50
22. Yamamura K., Sasaki H., Nakashima M., Ichikawa M., Mukai T., Nishida K., Nakamura J. Characterization of ocular pharmacokinetics of beta-blockers using a diffusion model after instillation. Pharm Res. 16:1999;1596-1601
23. Friederich S.W., Saville B.A., Cheng Y-.L., Rootman D.S. Pharmacokinetic differences between ocular inserts and eyedrops. J Ocul Pharm Ther. 12:1996;5-18
24. Jani R., Rhone E. Ion exchange resin technology for ophthalmic applications. Rathbone M.J., et al. Modified-release drug delivery technology. 2003;315-328 Marcel Dekker; Inc., New York